{{chembox
| Watchedfields = changed
| verifiedrevid = 444589978
| ImageFile = Imuracetam.svg
| ImageSize = 140px
| IUPACName = ''N'',''N'''-Bis[(2-oxopyrrolidin-1-yl)methyl]urea
| OtherNames = 
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 972FNV35ZM
| PubChem = 163319
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 143327
| InChI = 1/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18)
| InChIKey = WMKONRFEZGAHTE-UHFFFAOYAT
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H18N4O3/c16-9-3-1-5-14(9)7-12-11(18)13-8-15-6-2-4-10(15)17/h1-8H2,(H2,12,13,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WMKONRFEZGAHTE-UHFFFAOYSA-N
| CASNo_Ref = {{cascite|correct|??}}
| CASNo =67542-41-0
| ChEMBL = 2106342
| SMILES = O=C(NCN1C(=O)CCC1)NCN2C(=O)CCC2
}}
|Section2={{Chembox Properties
| C=11 | H=18 | N=4 | O=3
| Appearance = 
| Density = 
| MeltingPtC = 184.5
| MeltingPt_ref= <ref name=Ganellin>{{cite book | title = Dictionary of Pharmacological Agents | volume = 3 |author1=C.R. Ganellin |author2=David J. Triggle | publisher = CRC Press | date = 1996}}</ref>
| BoilingPt = 
| Solubility = }}
|Section5={{Chembox Pharmacology
| AdminRoutes = 
| Bioavail = 
| Metabolism = 
| HalfLife = 
| ProteinBound =
| Excretion =
| Legal_status = 
| Legal_US = 
| Legal_UK =
| Legal_AU = 
| Legal_CA = 
| Pregnancy_category = 
| Pregnancy_AU = 
| Pregnancy_US = }}
}}

'''Imuracetam''' is a drug of the [[racetam]] family.<ref>Avetisyan SA, Kocharov SL, Azaryan LV, Dzhagatspanyan IA, Melikyan GG. Synthesis and psychotropic activity of new 2-pyrrolidone derivatives. ''Pharmaceutical Chemistry Journal''. 1998; 32(2):55-58.</ref>  It was under development in the 1970s, but was never marketed.<ref name=Ganellin/>

==References==
{{reflist}}

{{Racetams}}

[[Category:Racetams]]
[[Category:Pyrrolidones]]
[[Category:Ureas]]
[[Category:Abandoned drugs]]

{{nervous-system-drug-stub}}